Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Cardiologist the subject of several malpractice claims for allegedly performing unnecessary heart operations

One patient received a total of 41 stents from 2004 to 2013. He said the experience was so hard that he feared he would be driven to suicide. 

CorPath GRX System siemens

Corindus, acquired back in 2019, is now Siemens Healthineers Endovascular Robotics

The company's most well-known product within the industry is the CorPath GRX System, a second-generation robotics solution used by interventional cardiologists during PCI and other interventional procedures.

Juan Granada discusses new cardiac technology AHA22.

VIDEO: 2 key technologies to rapidly advance cardiovascular care

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.

Boston Scientific to acquire majority stake of interventional device company for $523M

Acotec, founded in 2008, designs and distributes a wide range of medical devices used in interventional cardiology, including drug-coated balloons and thrombus aspiration catheters.

New risk score helps identify high-risk PCI patients

The risk assessment tool could help health systems and researchers alike determine when patients face greater odds of post-PCI complications. 

Interventional cardiology to join the Match in 2025

It is an announcement many interventional cardiologists have been waiting to hear for a long time. 

An updated look at the latest self-expandable and balloon-expandable TAVR devices

Researchers have completed a new analysis of the Evolut Pro and Pro+ devices from Medtronic and the Sapien 3 Ultra devices from Edwards Lifesciences, sharing the results in JACC: Cardiovascular Interventions.

FDA changes indications for Impella RP heart pump after dramatic shift in mortality rate

The Impella RP System is still associated with significant benefits, the FDA said, but there are certain high-risk patients who should no longer be eligible for treatment.

Displaying 465 - 472 of 2683

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.